Adoptive cell therapy consists of the isolation of TILs from the excised tumor, expansion of these cells by interleukin-2 (IL-2) treatment and re-infusion into lympho-depleted patients with treatment of IL-2 in addition. Here, IL2 is linked to neoplasm.